1. Home
  2. HLIT vs PHAT Comparison

HLIT vs PHAT Comparison

Compare HLIT & PHAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Harmonic Inc.

HLIT

Harmonic Inc.

HOLD

Current Price

$10.56

Market Cap

1.1B

Sector

Technology

ML Signal

HOLD

Logo Phathom Pharmaceuticals Inc.

PHAT

Phathom Pharmaceuticals Inc.

HOLD

Current Price

$11.99

Market Cap

1.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
HLIT
PHAT
Founded
1988
2018
Country
US
Employees
N/A
N/A
Industry
Radio And Television Broadcasting And Communications Equipment
Biotechnology: Pharmaceutical Preparations
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.1B
1.0B
IPO Year
1996
N/A

Fundamental Metrics

Financial Performance
Metric
HLIT
PHAT
Price
$10.56
$11.99
Analyst Decision
Buy
Strong Buy
Analyst Count
4
6
Target Price
$13.33
$17.33
AVG Volume (30 Days)
769.9K
828.5K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
0.10
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
$221.87
Revenue Next Year
$21.77
$80.37
P/E Ratio
$24.84
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.80
$2.21
52 Week High
$11.49
$18.31

Technical Indicators

Market Signals
Indicator
HLIT
PHAT
Relative Strength Index (RSI) 58.49 37.06
Support Level $9.87 $11.83
Resistance Level $10.92 $13.17
Average True Range (ATR) 0.42 0.82
MACD 0.08 -0.04
Stochastic Oscillator 76.79 7.78

Price Performance

Historical Comparison
HLIT
PHAT

About HLIT Harmonic Inc.

Harmonic Inc engaged in broadband access solutions that enable broadband operators to more efficiently and effectively deploy high-speed internet for data, voice, and video services for their customers and versatile and high-performance video delivery software, products, system solutions and services that enable its customers to efficiently create, prepare, store, playout and deliver a full range of high-quality broadcast and streaming video services to consumer devices, including televisions, personal computers, laptops, tablets, and smartphones. It has two segments, Broadband which provides broadband access solutions and related services, and Others; and Video business provides video processing and production and playout solutions and services, and Others.

About PHAT Phathom Pharmaceuticals Inc.

Phathom Pharmaceuticals Inc operates as a clinical-stage biopharmaceutical company. The firm is focused on developing and commercializing novel treatments for gastrointestinal, or GI, diseases. Its product comprises vonoprazan, an oral small-molecule potassium competitive acid blocker medicine that blocks acid secretion in the stomach. Vonoprazan shows rapid, potent, and durable anti-secretory effects and has demonstrated clinical benefits in the treatment of gastroesophageal reflux disease, and in combination with antibiotics for the treatment of Helicobacter pylori infection.

Share on Social Networks: